Cite
MLA Citation
Matteo Perrino et al.. “Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2‐B3) and thymic carcinoma previously treated with chemotherapy.” Cancer, vol. 128, no. 4, 2022, pp. 719–726. http://access.bl.uk/ark:/81055/vdc_100150567561.0x000062